Tocilizumab in Treatment for Patients With COVID-19

JAMA Intern Med. 2021 Jul 1;181(7):1019. doi: 10.1001/jamainternmed.2021.0401.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab